Paul Sufka Named Social Media Editor for New ACR Twitter Account A clinical rheumatologist with HealthPartners in St. Paul, Minn., Paul Sufka, MD, is conversant with social media: he’s been on Twitter for almost 10 years; has hosted an online rheumatology podcast; and blogs about physician self-care and using Twitter as a tool at medical…
Search results for: Twitter
Dr. Shervin Assassi: New Chair of the ACR Committee on Journal Publications
Shervin Assassi, MD, MS, was the child of two physicians. His mother practiced obstetrics, and his father was a trauma surgeon. It gave him an appreciation for the hard work that goes into medicine and a fascination for joints. He developed an interest in immunology while in medical school. “It was natural for me to…
Advocacy Begins at Home
As the frustration with changes in healthcare grows, and after speaking with the vociferous advocates who are part of the ACR, you have decided that you need to become involved in advocacy for your patients, your practice and your profession. Welcome to the fold. How to Help from Home Many people indicate they aren’t more…
Fellows Forum: Keep Up with the Literature & Organize Your Learning
At the close of my first year in fellowship, a co-fellow opened a packed cabinet behind her desk, and untold volumes of methodically annotated medical articles burst forth. Impressed not only by her diligence but also by the sheer volume of paper, I made a mental note to read more and to read more efficiently….
U.S. FDA Chief Gottlieb Resigns
WASHINGTON (Reuters)—U.S. Food and Drug Administration (FDA) Chief Scott Gottlieb said he plans to step down in a month, calling into question how the agency will handle critical issues, such as e-cigarette use among teens and efforts to increase competition in prescription drugs. The U.S. Department of Health and Human Services (HHS), which oversees the…
U.S. Senators Tell Drug Company Execs Pricing Is Morally Repugnant
WASHINGTON/NEW YORK (Reuters)—U.S. Senators called drug pricing practices “morally repugnant” and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on the rising costs of prescription medicines. Executives from Abbvie Inc., AstraZeneca PLC., Sanofi SA, Pfizer…
Rheumatology Advocacy in 2019
A belated Happy New Year to my fellow advocates! Here’s your first update for 2019 on what the rheumatology community should know is going on in Washington, D.C., right now. Current Climate On Jan. 3, the 116th Congress gaveled into session with Democrats in control of the House of Representatives and Republicans still the majority in the…
U.S. Lawmaker Launches Investigation into Pharma Drug Pricing
WASHINGTON (Reuters)—A top U.S. lawmaker has launched an investigation into pharmaceutical industry pricing practices, less than a week after he and fellow Democrats introduced legislation aimed at lowering medicine prices. Rep. Elijah Cummings (D-Md.), who chairs the U.S. House Oversight Committee, sent letters to 12 drug makers seeking information on price increases, investment in research…
Sen. Sanders, Rep. Cummings to Introduce Bill to Lower U.S. Drug Prices
WASHINGTON (Reuters)—U.S. Senator Bernie Sanders and Representative Elijah Cummings plan to introduce legislation on Thursday aimed at lowering the cost of prescription drugs for U.S. consumers. Democrats have been critical of efforts by the Trump administration to bring down drug prices after President Donald Trump promised to do so during his campaign and since being…
Maryland Judge to Weigh Obamacare Case
(Reuters)—Days after a judge in Texas declared that the Obamacare healthcare law is unconstitutional, Maryland’s Democratic attorney general on Wednesday will pursue his request that another judge rule the opposite way. The lawsuit brought by Maryland Attorney General Brian Frosh also seeks to challenge President Donald Trump’s appointment of Matthew Whitaker as acting attorney general,…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 23
- Next Page »